Clinical Trial Update: BioFreedom FIM Clinical Trial. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for the BioFreedom FIM study assessing treatment of stenotic lesions in native coronary arteries; the Phase 2 and Phase 3 trials have comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: Biosensors Europe SA | Conditions: Treatment Of Stenotic Lesions In Native Coronary Arteries. | Phase 2, Phase 3 | Status: COMPLETED